RD13-01 for Patients With r/r CD7+ T/NK Cell Hematologic Malignancies
Clinical trial NCT04538599 · COMPLETED
Trial details
- NCT number
- NCT04538599
- Sponsor
- He Huang
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-09-10
- Primary completion
- 2021-02-17
- Enrollment
- 12
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.